NCT04578756 Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder Status COMPLETED Phase PHASE3
NCT04578314 RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations Status COMPLETED Phase NA
NCT04562961 Diagnostic Announcement to Relatives of Patients With Schizophrenia Status UNKNOWN Phase NA
NCT04554121 Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing Status COMPLETED Phase NA
NCT04553835 Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients Status UNKNOWN Phase NA
NCT04551027 Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness Status UNKNOWN Phase NA
NCT04548622 Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results Status TERMINATED Phase NA
NCT04545294 Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia Status COMPLETED Phase NA
NCT04533724 Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia Status UNKNOWN Phase EARLY_PHASE1
NCT04531982 Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia Status COMPLETED Phase PHASE3
NCT04521868 A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients Status COMPLETED Phase PHASE2
NCT04520399 Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning Status UNKNOWN Phase N/A
NCT04518319 Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome Status SUSPENDED Phase PHASE2
NCT04511663 The Effectiveness of Assertive Community Treatment on Schizophrenic Patients Status COMPLETED Phase NA
NCT04510298 A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT04506905 Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011) Status COMPLETED Phase PHASE1
NCT04503954 Efficacy of Chronic Disease Self-management Program in People With Schizophrenia Status COMPLETED Phase NA